These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6810008)

  • 1. Modulation of cell-mediated alloimmunity by BCG. II. Induction of specific, nonadherent, non-T-killer cells by BCG and alloantigen.
    Murahata RI; Mitchell MS
    J Natl Cancer Inst; 1982 Sep; 69(3):613-8. PubMed ID: 6810008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine.
    Murahata RI; Mitchell MS
    J Natl Cancer Inst; 1982 Sep; 69(3):607-12. PubMed ID: 6981020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.
    Saxena RK; Adler WH
    J Immunol; 1979 Aug; 123(2):846-51. PubMed ID: 110883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of BCG (Bacillus Calmette Guérin) sensitization on the generation of tumor specific killer T cells].
    Takeuchi M; Kimoto M; Suzuki I; Nomoto K
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1980-6. PubMed ID: 6604499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allograft cytotoxicity. Two populations of effector cell detectable by cytolytic and cytostatic assays in vitro.
    Jones B; Jones TC; Roitt IM
    Immunology; 1977 Apr; 32(4):591-9. PubMed ID: 415967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allograft cytotoxicity. Role of T lymphocytes bearing a receptor for complement.
    Arnaiz-Villena A; Jones B; Roitt IM
    Immunology; 1975 Nov; 29(5):903-8. PubMed ID: 811554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal alloimmunisation in pregnancy. In vitro studies of T cell-dependent immunity to paternal alloantigens.
    Smith JA; Burton RC; Barg M; Mitchell GF
    Transplantation; 1978 Apr; 25(4):216-20. PubMed ID: 305673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunity to H-2 antigens. Characteristics of the effector cells as detected in the microcytotoxicity assay.
    Trostmann H; Pfizenmaier K; Wagner H; Röllinghoff M
    Transplantation; 1976 Jun; 21(6):446-53. PubMed ID: 1084606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on T cell clonal expansion. I. Suppression of killer T cell production in vivo.
    Kamat R; Henney CS
    J Immunol; 1975 Dec; 115(6):1592-8. PubMed ID: 810513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages.
    Jones B; Jones TC
    Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
    Paciucci PA; Macphail S; Zarling JM; Bach FH
    J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer.
    Sonoda T; Sugimura K; Ikemoto S; Kawashima H; Nakatani T
    Oncol Rep; 2007 Jun; 17(6):1469-74. PubMed ID: 17487406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific spontaneous cytotoxic activity in human T cell colonies.
    Price GB; Teh HS; Miller RG
    J Immunol; 1980 May; 124(5):2352-5. PubMed ID: 6767786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
    Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
    Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
    Raina S; Russo AJ; Jenkins D; Goldrosen MH
    Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor growth mediated by lymphocytes sensitized in vitro to a syngeneic murine teratocarcinoma 402AX.
    Bartlett PF; Fenderson BA; Edidin M
    J Immunol; 1978 Apr; 120(4):1211-7. PubMed ID: 641346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cytotoxicity expressed by cells active against established tumors in vivo.
    Tuttle RL; Knick VC; Stopford CR; Weck CJ; Wolberg G
    Cancer Res; 1981 Jul; 41(7):2633-9. PubMed ID: 6788359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell-dependent nonspecific cytotoxicity induced by culture of mouse spleen cells against natural killer-insensitive tumor cells.
    Kiyohara T; Tanino T; Egawa K
    Jpn J Exp Med; 1982 Aug; 52(4):201-8. PubMed ID: 7176145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of alloantigens LY-5 and LY-6 on cytotoxic effector cells.
    Woody JN; Feldmann M; Beverley PC; McKenzie IF
    J Immunol; 1977 May; 118(5):1739-43. PubMed ID: 323358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular basis for adriamycin-induced augmentation of cell-mediated cytotoxicity in culture.
    Ehrke MJ; Ryoyama K; Cohen SA
    Cancer Res; 1984 Jun; 44(6):2497-504. PubMed ID: 6426781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.